Past News
2008
Appointment of new Director for the Company
October 2008Mr. Patrick Terry joins Sirius' Board of Directors. As one of the co-founders of Genomic Health, a leading molecular diagnostic company, Mr. Terry brings his expertise in the field of personalized medicine to Sirius.
Appointment of Senior Vice President, Clinical & Regulatory Affairs
October 2008Alexandra Mancini joins Sirius as the new Senior Vice President, Clinical and Regulatory Affairs. Ms. Mancini brings her 25 years of experience in clinical trial implementation and regulatory process management expertise to Sirius.
Appointment of new Director for the Company
January 2008Dr. H. Christian Fibiger joins Sirius' Board of Directors. Dr. Fibiger was previously the Vice President and Global Head of Neuroscience at Amgen. He brings his deep understanding of the drug development process to Sirius.
Sirius selected as an Emerging Rocket Company for 2008 by Rocket Builders
January 24, 2008The Emerging Rockets list profiles technology companies from multiple technology sectors with great potential for investment and market breakthroughs in the coming year. Read the full press release here.
Appointment of new Director for the Company
January 23, 2008Dr. Heiner Dreismann joins Sirius' Board of Directors. As past CEO of Roche Molecular Systems, Dr. Dreismann is a veteran of the molecular diagnostic industry and brings his 20 years of extensive management and business experience to Sirius.
2007
Appointment of Vice President, Business Development
September 10, 2007Chris Wagner joins Sirius Genomics as Vice President, Business Development. Mr. Wagner brings 15 years of collective experience in marketing, sales and business development to Sirius. Celia Courchene will now focus on internal development taking the role of Vice President, Corporate Affairs.
Appointment of Vice President, Intellectual Property
August 13, 2007Jennifer Kaufman-Shaw joins Sirius Genomics as the new Vice President, Intellectual Property. Dr. Kaufman-Shaw brings her expertise as scientific patent counsel with over 15 years of legal experience to Sirius.
New Website Launched
March 22, 2007Sirius Genomics launched new website and logo.
2006
Appointment of Vice President, Business Development
October 1, 2006Celia Courchene joined Sirius as the new Vice President, Business Development. Ms Courchene brings 20 years of experience and expertise in business development and business law to the Company.
Closing of Series A Financing
June 23, 2006Sirius Genomics closed it Series A Financing raising $6.3 million.
Signing of Sirius-Tm Bioscience Agreement
March 17, 2006Sirius Genomics and Tm Bioscience sign a development and license agreement to jointly collaborate on the development and commercialization of diagnostic kits to identify patients who will respond to current available treatments for sepsis.
Appointment of new CEO
February 1, 2006Sirius Genomics is pleased to announce the recent appointment of Dr. Brad Popovich as President and CEO. Dr. Popovich joined the company last year as Chief Operating Officer. Dr. James Russell, former President and CEO, has been appointed as Chief Medical Officer in order to refocus his scientific expertise to expand the research, discovery and development side of the company.